← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sound Pharmaceuticals, Inc.
Seattle, WA
$4,334,965
Total funding
2
Grants
Funding over time
peak $3.1M · FY2021–22$5M$3.8M$2.5M$1.3M$0
'21
'22
Funding mix
By agency
NIH$4,334,965 · 2
By mechanism
U01$4,174,965 · 1
R43$160,000 · 1
Investigators at Sound Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients$3,082,804
U01 · FY2021 · TR
Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients$1,092,161
U01 · FY2022 · TR
Cellular regeneration in the organ of Corti$160,000
R43 · FY2003 · DC